Comparing Esbriet vs Pirfenidone
| Esbriet (pirfenidone) | Pirfenidone |
|
|---|
| Esbriet (pirfenidone) | Pirfenidone |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Idiopathic Pulmonary Fibrosis. Esbriet may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Idiopathic Pulmonary Fibrosis. Pirfenidone may also be used for purposes not listed in this medication guide. |
Related suggestions Idiopathic Pulmonary Fibrosis
Popular comparisons
|
|||||||||||||||
| More about Esbriet (pirfenidone) | More about Pirfenidone | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Esbriet has an average rating of 7.5 out of 10 from a total of 11 ratings on Drugs.com. 64% of reviewers reported a positive effect, while 9% reported a negative effect. |
Pirfenidone has an average rating of 7.1 out of 10 from a total of 25 ratings on Drugs.com. 48% of reviewers reported a positive effect, while 8% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
|
View all Esbriet side effects |
View all Pirfenidone side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
|
Lower cost generic |
|||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Esbriet prices |
View all Pirfenidone prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
|
N/A |
Esbriet | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
3 hours |
3 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 161 drugs are known to interact with Esbriet:
|
A total of 161 drugs are known to interact with Pirfenidone:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
|
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
October 15, 2014 |
October 15, 2014 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Ofev
Ofev (nintedanib) is used to treat a lung disease called idiopathic pulmonary fibrosis, and ...
Actimmune
Actimmune is used for chronic granulomatous disease, cutaneous t-cell lymphoma, idiopathic ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Accutane
Accutane (isotretinoin) is a form of vitamin A and is used to treat severe nodular acne. Includes ...
Adakveo
Adakveo (crizanlizumab-tmca) is used for the prevention of vasoocclusive crises (VOCs) in patients ...
Ammonul
Ammonul is used to treat a condition caused by too much ammonia in the blood. Includes Ammonul side ...
Amnesteem
Amnesteem is used for acne, acute nonlymphocytic leukemia, granuloma annulare, rosacea
Amondys 45
Amondys 45 (casimersen) is used to treat Duchenne muscular dystrophy (DMD) with a genetic mutation ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.